173 related articles for article (PubMed ID: 23171359)
21. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
[TBL] [Abstract][Full Text] [Related]
22. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.
Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC
J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455
[TBL] [Abstract][Full Text] [Related]
24. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
[TBL] [Abstract][Full Text] [Related]
25. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
26. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
[TBL] [Abstract][Full Text] [Related]
27. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
28. Envelope variation as a primary determinant of lentiviral vaccine efficacy.
Craigo JK; Zhang B; Barnes S; Tagmyer TL; Cook SJ; Issel CJ; Montelaro RC
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15105-10. PubMed ID: 17846425
[TBL] [Abstract][Full Text] [Related]
29. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
31. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
Li F; Craigo JK; Howe L; Steckbeck JD; Cook S; Issel C; Montelaro RC
J Virol; 2003 Jul; 77(13):7244-53. PubMed ID: 12805423
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
[TBL] [Abstract][Full Text] [Related]
33. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
McGuire TC; Fraser DG; Mealey RH
Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
[TBL] [Abstract][Full Text] [Related]
35. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
[TBL] [Abstract][Full Text] [Related]
36. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
[TBL] [Abstract][Full Text] [Related]
37. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.
Lonning SM; Zhang W; Leib SR; McGuire TC
J Virol; 1999 Apr; 73(4):2762-9. PubMed ID: 10074123
[TBL] [Abstract][Full Text] [Related]
38. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
Wang XF; Wang YH; Bai B; Zhang M; Chen J; Zhang X; Gao M; Wang X
J Virol; 2021 Nov; 95(23):e0108721. PubMed ID: 34495693
[TBL] [Abstract][Full Text] [Related]
39. Genetic Evolution during the development of an attenuated EIAV vaccine.
Wang XF; Lin YZ; Li Q; Liu Q; Zhao WW; Du C; Chen J; Wang X; Zhou JH
Retrovirology; 2016 Feb; 13():9. PubMed ID: 26842878
[TBL] [Abstract][Full Text] [Related]
40. EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy.
Craigo JK; Montelaro RC
Curr HIV Res; 2010 Jan; 8(1):81-6. PubMed ID: 20210783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
